Research Analysts Offer Predictions for SBC Q1 Earnings

SBC Medical Group Holdings Incorporated (NASDAQ:SBC) – Research analysts at Zacks Small Cap issued their Q1 2025 earnings per share estimates for shares of SBC Medical Group in a research report issued to clients and investors on Wednesday, April 2nd. Zacks Small Cap analyst M. Marin expects that the company will post earnings per share of $0.06 for the quarter. The consensus estimate for SBC Medical Group’s current full-year earnings is $5.02 per share. Zacks Small Cap also issued estimates for SBC Medical Group’s Q1 2025 earnings at $0.06 EPS, Q2 2025 earnings at $0.06 EPS, Q2 2025 earnings at $0.06 EPS, Q3 2025 earnings at $0.07 EPS, Q3 2025 earnings at $0.07 EPS, FY2025 earnings at $0.26 EPS and FY2025 earnings at $0.26 EPS.

SBC Medical Group (NASDAQ:SBC) last released its quarterly earnings results on Friday, March 28th. The company reported $0.18 EPS for the quarter, topping the consensus estimate of $0.17 by $0.01. The company had revenue of $57.90 million for the quarter, compared to analysts’ expectations of $56.34 million.

SBC Medical Group Stock Performance

Shares of SBC Medical Group stock opened at $3.29 on Friday. SBC Medical Group has a one year low of $2.62 and a one year high of $12.50. The company has a quick ratio of 2.76, a current ratio of 2.79 and a debt-to-equity ratio of 0.06. The stock’s fifty day moving average price is $4.22.

SBC Medical Group Company Profile

SBC Medical Group Holdings Incorporated, through its subsidiaries, provides services to support the operation of clinics which deliver specialized medical services in the areas of cosmetic medicine, esthetic dentistry and Androgenetic Alopecia or AGA, primarily in Japan and centered on the SBC Shonan Beauty Clinic Brand.